© 2019 by Arctic Pharma AS.

Our medicinal chemist Karl gave an interactive lecture based on Arctic Pharma's research to final year students at Ullern Videregående Skole, followed by tours of our labs in the Oslo Cancer Cluster Incubator.

February 2019

Elsevier publish a case study of our involvement in 'The Hive' program, in which we utilized Elsevier's suite of R&D solutions to support our research activities.

Our new chemistry lab is up and running.

November 2018

Our medicinal chemist Karl gave a lecture in the chemistry department at the University of Oslo where he presented the exciting research that Arctic Pharma is carrying out in developing novel therapeutics for the treatment of glycolytic cancers.

October 2018

Claudia and Kathrin got involved with the Rosa sløyfe-løpet ('the Pink ribbon run') in Oslo, which was organised by Kreftforeningen (Norwegian Cancer Society) and Brystkreftforeningen as part of Breast Cancer Awareness Month. Proceeds from the race go towards breast cancer research.

October 2018

Our CEO Claudia A. McDonald Bøen presented Arctic Pharma's research in front of a wide-range of triple negative breast cancer (TNBC) experts at a special symposium entitled 'Breast Cancer: The Triple Negative Paradox' held at the Oslo Cancer Cluster.

August 2018

Claudia, Steffi and Karl attended the '19th Annual Drug Discovery Summit' in Berlin. The team enjoyed a wide variety of presentations and the event served as a great opportunity to have discussions with a range of different companies and scientists, some of which we hope may lead to fruitful collaborations in the future!

June 2018

Arctic Pharma had the pleasure of participating in welcoming King Harald and Queen Sonja of Norway and President Andrej Kiska of Slovakia to the Oslo Cancer Cluster as a part of the state visit. During their tour of the OCC incubator two of our scientists, Steffi and Karl, had the opportunity to describe to the King, Queen and President some of the exciting research Arctic Pharma is carrying out along the road to developing a new treatment for cancer.

June 2018
December 2018
November 2018
logo_medium-300x272.png